Pantouni L 75mg/40mg Capsule SR
Marketer
Unimet Lifecare
Salt Composition
Levosulpiride (75mg) + Pantoprazole (40mg)
Overview Pantouni L 75mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with Pantouni L 75mg/40mg sustained-release capsules. These capsules alleviate symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Pantouni L should be taken on an empty stomach, following your doctor's prescribed dosage and regimen. Treatment duration depends on your individual response and should continue as directed to prevent symptom recurrence and disease exacerbation. Inform your physician of all other medications you're using, as interactions are possible. Common, typically transient side effects include nausea, vomiting, diarrhea, headache, fever, abdominal pain, rash, and flatulence. Report any concerning side effects immediately. Dizziness is a potential side effect; avoid driving or mentally demanding tasks until its impact is known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Lifestyle adjustments, such as consuming cold milk and omitting spicy foods, chocolate, coffee, and hot tea, can improve outcomes. Prior to commencing treatment, disclose any kidney conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Pantouni L 75mg/40mg Capsule SR
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Pantouni L 75mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Pantouni L 75mg/40mg SR Capsules. Ingest the capsules whole; avoid crushing, chewing, or breaking them. Administer on an empty stomach.
Common Side effects of Pantouni L 75mg/40mg Capsule SR:
- Stomach pain
- Vomiting
- Diarrhea
- Headache
- Nausea
- Flatulence
- Fundic gland polyps
- Fever
- Skin rash
- Dizziness
How to use Pantouni L 75mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Pantouni L 75mg/40mg SR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
How Pantouni L 75mg/40mg Capsule SR works:
Levosulpiride and pantoprazole, combined at 75mg/40mg in a sustained-release capsule (Pantouni L), provide dual-action therapy.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pantouni L 75mg/40mg extended-release capsules and alcohol can result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Extended-release Pantouni L 75mg/40mg capsules present a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Prolonged-release Pantouni L 75mg/40mg capsules are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Pantouni L 75mg/40mg SR Capsules, which can induce drowsiness, dizziness, or dyskinesia. Consequently, patients should refrain from driving or operating machinery that necessitates close attention.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Pantouni L 75mg/40mg sustained-release capsules. Dosage modification of Pantouni L 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
The extended-release Pantouni L 75mg/40mg capsule requires careful administration in individuals exhibiting severe hepatic impairment. Dosage modification for Pantouni L 75mg/40mg Capsule SR may be necessary. Physician consultation is advised.
What if you forget to take Pantouni L 75mg/40mg Capsule SR :
Should you forget to take a Pantouni L 75mg/40mg SR Capsule, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Pantouni L 75mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently